Proteinase-Activated Receptor-2 (PAR2): A Tumor Suppressor in Skin Carcinogenesis
- 1 September 2007
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 127 (9) , 2245-2252
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg (STE2/103/04)
- Deutsche Forschungsgemeinschaft (SFB 293-A14, SFB 492-B13)
- Bundesministerium für Forschung, Technologie und Raumfahrt
This publication has 35 references indexed in Scilit:
- Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathwaysBiochemical and Biophysical Research Communications, 2006
- Protease-activated Receptor 2 in Colon CancerJournal of Biological Chemistry, 2004
- Trypsin IV, a Novel Agonist of Protease-activated Receptors 2 and 4Journal of Biological Chemistry, 2004
- Amplification of MMP‐2 and MMP‐9 production by prostate cancer cell lines via activation of protease‐activated receptorsThe Prostate, 2004
- Role of proteinase‐activated receptors in cutaneous biology and diseaseDrug Development Research, 2003
- Protease-Activated Receptor-1–Mediated DNA Synthesis in Cardiac Fibroblast Is via Epidermal Growth Factor Receptor TransactivationCirculation Research, 2002
- Proteinase-Activated Receptor-2 (PAR2): Vascular Effects of a PAR2-Derived Activating Peptide via a Receptor Different than PAR2The Journal of Pharmacology and Experimental Therapeutics, 2002
- The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastomaJournal of Neural Transmission, 2001
- Suppression of Keratinocyte Growth and Differentiation by Transforming Growth Factor β1 Involves Multiple Signaling PathwaysJournal of Investigative Dermatology, 2001
- Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumorsCarcinogenesis, 1991